Faculty: Neil Barber, Kevin Zorn and Sam Mouli

Moderator: Naeem Bhojani

Dr. Neil Barber

Appointed as a Consultant Urological Surgeon to Frimley Park Hospital in 2005, Neil Barber is Clinical Lead for Urology at Frimley Health NHS Foundation Trust and Director of the Frimley Renal Cancer Centre and the Frimley Benign Prostate Clinical Research Centre.

His particular subspecialist interests in managing waterworks symptoms in women and men, particularly for men suffering with BPH, has led to his involvement in new treatments including the introduction to NHS England of the Greenlight laser in 2002, Urolift in 2014, Aquablation of the prostate using the Aquabeam system and iTind in 2019. Neil has been involved in numerous high quality national, European and global studies as well as acting as an advisor to NICE in this field.


Dr. Kevin Zorn

Dr. Kevin Zorn is a dual-board-certified (US and Canada), minimally-invasive urologist, oncology-fellowship trained at the University of Chicago. As a native Montrealer, Dr. Zorn received his undergraduate and MD degrees from McGill University where he completed his residency in urology in 2005. His main focus of clinical and scientific interest is in the surgical treatment of benign prostatic hyperplasia (BPH) and prostate cancer. Other than his focus on robotic surgery with over 2500 robotic prostatectomy cases performed, Dr. Zorn is also the national Canadian surgical trainer and international proctor for the Greenlight XPS 180W laser since 2012. He has also an active proctor from residents to international urologists with integration of simulation experience. He has also been an invited speaker/visiting professor for his academic work on laser therapies and techniques for BPH management. He was the first in Canada to utilize the latest version of the Greenlight 180W XPS laser for BPH and has pioneered an enucleation-like technique to standardize Greenlight technique. Not only has Dr. Zorn helped with the national BPH guidelines, he is also an active with various other minimally invasive therapies with Urolift, Rezum, Aquablation and other cutting edge technologies including Optilume and Zenflow.

Dr. Zorn is an active researcher and a dedicated teacher to his urology residents and fellows. He has published extensively on prostate surgical care with over 250 peer-reviewed papers and 12 book chapters (http://www.ncbi.nlm.nih.gov/pubmed?term=zorn%20kc). He has received awards for his clinical work, research and teaching from the AUA and Endourological Society. He is also a reviewer for many urological journals and has been awarded Best Reviewer for Prostate Cancer in 2009 and 2010 for the Journal of Urology. He has also been a member of the American Urological Association (AUA) educational task force for the development of the laparoscopic and robotic urologic surgery curriculum and has served AUA hands-on course director for the annual AUA annual meetings for 7 years. Dr. Zorn has also helped develop and organize the University of Chicago Robotic Radical Prostatectomy Course (a symposium of the world's top robotic surgeons) which began in 2007. He has worked closely with AMS/BSCI through center of excellence (COE) training activities to foster Greenlight XPS training.  Most recently, he has been invited as a member of the CUA BPH Guidelines Committee as well as the CUA continuing professional development (CPD) Committee.  As such, Dr. Zorn has a passion for academics and peer-related education.

Over the past 10 years, Dr. Zorn has returned home to Montreal to develop the University of Montreal (CHUM) robotic and laser BPH program. He serves as Associate Professor of Surgery and Director of Robotic Surgery.


Dr. Sam Moull

Dr. Sam Mouli, MD, MS is an Assistant Professor in the Section of Interventional Radiology at the Feinberg School of Medicine at Northwestern University. He completed his medical training, master’s degree, radiology residency, and interventional radiology fellowship at Northwestern University.

He is the Director of the Interventional Oncology Laboratory as well as Director of Translational Interventional Radiology Research for the Center for Translational Imaging of Northwestern University’s Feinberg School of Medicine. He oversees rapidly developing translational research program focused specifically upon the application of novel therapies in the setting of image-guided therapy for GI and GU malignancies. Over the past ten years, with colleagues at Northwestern University, he has been a key collaborator in many pre-clinical and clinical research studies. His clinical interests include Interventional Oncology and Prostate Artery Embolization.


Dr. Naeem Bhojani

Dr. Naeem Bhojani was born and raised in Montreal. He obtained a BSc in Microbiology and Immunology and another in Physiotherapy from McGill University in 2001 and then completed medical school and urology residency at the University of Montreal. In 2011, Dr. Bhojani spent 2 years with Dr. Lingeman at Indiana University completing his Fellowship in BPH and Stone Disease. Dr. Bhojani was recruited by the University of Montreal in 2013 to build and develop Comprehensive Kidney Stone and BPH Programs. At the University of Montreal, he has the rank of Associate Professor and clinical researcher. Dr. Bhojani has published extensively in stone disease and BPH. In 2017, Dr. Bhojani was named the AUA’s Young urologist of the year representing the NSAUA. In 2019, Dr. Bhojani was awarded the prestigious clinical research scholar award from the FRQ-S.